STOCK TITAN

If You Invested in Oryzon Genomics SA (ORYZF)

Healthcare · Biotechnology · OTC
See the ORYZF overview
ORYZF has not traded since Sep 30, 2026. Its last close was $3.10, so every figure on this page ends there and the 1, 5 and 10 year results count back from that close.
$1,000 invested 1 Year Before Its Last Close
N/A
Comparable prices start Apr 29, 2026
$1,000 invested 5 Years Before Its Last Close
N/A
Comparable prices start Apr 29, 2026
$1,000 invested 10 Years Before Its Last Close
N/A
Comparable prices start Apr 29, 2026

What $1,000 or $10,000 in ORYZF Was Worth at Its Last Close

Real historical value by amount invested and how long before the last close
If you invested 1 year before 5 years before 10 years before Since Apr 29, 2026
$1,000 — — — $927 -7%
$10,000 — — — $9,274 -7%

Based on real historical closing prices adjusted for stock splits, without dividends, through the latest market close. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results. We start ORYZF on Apr 29, 2026 because the prices we hold from before that date cannot be compared with the later ones, and a return measured across the two would be wrong.

Custom Calculation

Choose your own date and amount for ORYZF

$1,000 Investment Over Time

ORYZF vs S&P 500

Year-by-Year Returns

ORYZF annual performance
Year Start Price End Price Annual Return Cumulative
2026Apr 29 to Sep 30 $3.34 $3.10 -7.3% -7.3%

About Oryzon Genomics SA

Healthcare · OTC

Market Cap
$253.9M
Last Close
$3.10
View full ORYZF overview

Frequently Asked Questions

Oryzon Genomics SA investment returns

How much was $1,000 invested in Oryzon Genomics SA worth at its last close?

Limited historical data is available for ORYZF. The prices we can compare start on 2026-04-29.

Has Oryzon Genomics SA outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare ORYZF performance over available time periods.

For informational and educational purposes only, not investment advice.